Literature DB >> 3289598

Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.

D Maclean1, E T Mitchell, R R Coulson, T J Fitzsimons, D G McDevitt.   

Abstract

1. In a double-blind, randomised, three-way-crossover study, 25 patients with sitting diastolic blood pressure between 95 and 120 mm Hg (Phase V) after 4 weeks' run-in on atenolol 50 mg twice daily, received atenolol 50 mg twice daily alone, atenolol 50 mg plus nifedipine 20 mg each twice daily and atenolol 50 mg plus nifedipine 40 mg each twice daily in three treatment periods each lasting 4 weeks. 'Washout' periods were not included. 2. The two combination treatment regimes lowered the 12 h post-dose blood pressure more effectively than did atenolol alone, but the high dose nifedipine combination was no more effective than the low dose nifedipine combination. Sitting systolic BP (+/- s.e. mean) at the end of each period was 174 +/- 5 mm Hg after the atenolol run-in, 170 +/- 5 mm Hg with atenolol alone, 156 +/- 5 mm Hg with the low dose combination and 158 +/- 4 mm Hg with the high dose combination. Corresponding diastolic BP readings were 106 +/- 2 mm Hg, 106 +/- 2 mm Hg, 97 +/- 2 mm Hg and 99 +/- 2 mm Hg respectively. 3. Side-effects tended to occur less commonly with the low dose of the fixed combination than with atenolol alone. An increased number of side-effects occurred with the 40 mg twice daily doses of nifedipine, particularly flushing/erythema, oedema of the ankles/feet, and a hot feeling in the legs. These differences did not reach significance. 4. Overall compliance was good (98 +/- 0.7 s.e. mean %) and was similar within the different treatment regimes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289598      PMCID: PMC1387803          DOI: 10.1111/j.1365-2125.1988.tb03325.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol.

Authors:  P Lund-Johansen; O J Ohm
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

2.  Incidence and importance of metabolic side-effects during antihypertensive therapy.

Authors:  D Elmfeldt; G Berglund; H Wedel; L Wilhelmsen
Journal:  Acta Med Scand Suppl       Date:  1983

3.  Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up.

Authors:  M B Murphy; P J Lewis; E Kohner; B Schumer; C T Dollery
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

4.  Relationship between the antihypertensive effect and steady-state plasma concentration of nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  O Lederballe Pedersen; C K Christensen; E Mikkelsen; K D Rämsch
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

5.  Diuretic-induced hypokalemia.

Authors:  J P Knochel
Journal:  Am J Med       Date:  1984-11-05       Impact factor: 4.965

6.  Adverse interaction between nifedipine and beta-blockade.

Authors:  L H Opie; D A White
Journal:  Br Med J       Date:  1980-11-29

7.  Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol.

Authors:  L H Opie; L Jee; D White
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

8.  Thiazide diuretics, hypokalemia and cardiac arrhythmias.

Authors:  J W Hollifield; P E Slaton
Journal:  Acta Med Scand Suppl       Date:  1981

9.  Role of nifedipine in treatment of hypertension.

Authors:  M B Murphy; A J Scriven; C T Dollery
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-23

10.  Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs.

Authors:  C K Christensen; O Lederballe Pedersen; E Mikkelsen
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

View more
  7 in total

Review 1.  Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

Authors:  D A Sica
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

2.  Enalapril and nifedipine in the treatment of mild to moderate essential hypertension: a 6 month comparison.

Authors:  D Maclean; L E Ramsay; P J Richardson
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 3.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

4.  Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.

Authors:  D Maclean; E T Mitchell; R Lewis; N Irvine; J S McLay; J McEwen; R R Coulson; N D Slater; T J Fitzsimons; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

5.  Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.

Authors:  D Maclean; E T Mitchell; E M Laing; F C Macdonald; K J Gough; R J Dow; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 6.  [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].

Authors:  A Krivitzky; G Nguyen; Y Gaudouen; M Legrand; R Cohen
Journal:  Drugs       Date:  1998       Impact factor: 9.546

7.  Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.

Authors:  S H Thomas
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.